⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TEVA News
Teva Pharmaceutical Industries Limited American Depositary Shares
CCB Investment Losses: Coastal Financial Banking Services Issues Lead to 43% Stock Drop – BFA Law Reminds Investors of the Pending Securities Fraud Investigation
globenewswire.com
CCB
TSLA
TEVA
RXT Investment Losses: Rackspace Technology AI Effort Issues Lead to 33% Stock Drop – BFA Law Reminds Investors of the Pending Securities Fraud Class Action
globenewswire.com
RXT
AMD
TSLA
TEVA
Alvotech announces FDA acceptance for review of Biologics License Application for AVT80, expanding proposed biosimilar program for Entyvio® to subcutaneous presentations
globenewswire.com
ALVO
TEVA
Breast Cancer Therapeutics Market Size to Reach USD 95.14 Billion at a CAGR of 9.20% from 2035 – SNS Insider
globenewswire.com
PFE
LLY
MRK
GILD
ABBV
BMY
AMGN
PBYI
GSK
TEVA
EXEL
Investor Notice: Cardinal Infrastructure (NASDAQ:CDNL) Investigated for Potentially Misleading Investors in Securities Fraud Investigation – Contact BFA Law if You Lost Money
globenewswire.com
CDNL
TSLA
TEVA
Teva Announces Proposed Acquisition of a Novel Neuroscience Product Reinforcing Disciplined Business Development Approach Under Pivot to Growth Strategy
globenewswire.com
TEVA
Specialty Pharmaceuticals Market (2026-2031) - Rising Prevalence of Chronic and Rare Diseases Drives Growth
globenewswire.com
ABBV
AMGN
AZN
BIIB
BMRA
BMY
JNJ
MRK
NVS
PFE
REGN
SNY
TEVA
VRTX
Cytotoxic Drugs Market Report Now Available — Forecasts Market Growth from $16.21B (2026) to $21.06B by 2031, Profiling Pfizer, Roche, Novartis, AstraZeneca, Sanofi, and 15 Other Key Players
globenewswire.com
PFE
NVS
AZN
SNY
LLY
JNJ
MRK
AMGN
BIIB
GILD
BMY
ABBV
XRAY
VTRS
TEVA
SUN
Global Topical Drug Delivery Market to Reach $362.3 Billion by 2031, Driven by Rising Prevalence of Skin Disorders and Innovation in Non-Invasive Delivery Technologies
globenewswire.com
ABBV
ALM
BHC
GILD
GSK
SNY
SOLV
TEVA
Multiple System Atrophy Clinical Trial Pipeline Gains Momentum: 22+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
globenewswire.com
ASMB
IONS
BIIB
ALT
TEVA
ANVS
SUPN
ABBV
AVXL
MRK
KAR
VNDA